Mrv0541 02231217002D 8 7 0 0 1 0 999 V2000 -0.1914 0.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5230 1.1270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2375 0.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9520 1.1270 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.9520 1.9520 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.6664 0.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3809 1.1270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.6664 -0.1105 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 6 0 0 0 4 6 1 0 0 0 0 6 7 1 0 0 0 0 6 8 2 0 0 0 0 M END > DB04185 > drugbank > CCC[C@H](N)C(O)=O > InChI=1S/C5H11NO2/c1-2-3-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 > SNDPXSYFESPGGJ-BYPYZUCNSA-N > C5H11NO2 > 117.1463 > 117.078978601 > 3 > 19 > -0.002912134606966821 > 12.508865801242544 > 1 > 2 > 0 > 0 > (2S)-2-aminopentanoic acid > -2.04 > -1.8733752172778175 > 0.26 > 0 > 0 > 0 > 0 > 2.7136746618065284 > 9.526860379684686 > 63.32 > 29.622300000000003 > 3 > 1 > 2.12e+02 g/l > tetrahydrofolic acid > 0 > DB04185 > EXPT00144; EXPT02397; DB03519 > experimental > Norvaline > (S)-2-Aminopentanoic acid; 2-Aminopentanoic acid; 2-Aminovaleric acid; L-2-aminopentanoic acid; L-2-Aminovaleric acid; L-Norvaline $$$$